| Perioperative treatment in resectable gastric cancer: current perspectives and future directions A Petrillo, L Pompella, G Tirino, A Pappalardo, MM Laterza, M Caterino, ... Cancers 11 (3), 399, 2019 | 67 | 2019 |
| What’s new in gastric cancer: the therapeutic implications of molecular classifications and future perspectives G Tirino, L Pompella, A Petrillo, MM Laterza, A Pappalardo, M Caterino, ... International Journal of Molecular Sciences 19 (9), 2659, 2018 | 49 | 2018 |
| Novel therapeutic opportunities in neoadjuvant setting in urothelial cancers: a new horizon opened by molecular classification and immune checkpoint inhibitors ML Iacovino, CC Miceli, M De Felice, B Barone, L Pompella, F Chiancone, ... International journal of molecular sciences 23 (3), 1133, 2022 | 38 | 2022 |
| Pancreatic cancer molecular classifications: from bulk genomics to single cell analysis L Pompella, G Tirino, A Pappalardo, M Caterino, A Ventriglia, V Nacca, ... International Journal of Molecular Sciences 21 (8), 2814, 2020 | 30 | 2020 |
| Neutrophil to lymphocyte ratio as a predictor of poor prognosis in metastatic pancreatic cancer patients treated with nab‐paclitaxel plus gemcitabine: a propensity score analysis J Ventriglia, A Petrillo, M Huerta Alváro, MM Laterza, B Savastano, ... Gastroenterology Research and Practice 2018 (1), 2373868, 2018 | 29 | 2018 |
| Results of the observational prospective RealFLOT study E Giommoni, D Lavacchi, G Tirino, L Fornaro, F Iachetta, C Pozzo, ... BMC cancer 21, 1-11, 2021 | 28 | 2021 |
| Adjuvant treatment in pancreatic cancer: shaping the future of the curative setting A Pappalardo, EF Giunta, G Tirino, L Pompella, P Federico, B Daniele, ... Frontiers in Oncology 11, 695627, 2021 | 19 | 2021 |
| First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: a good choice beyond age A Petrillo, A Pappalardo, F Calabrese, G Tirino, L Pompella, J Ventriglia, ... Journal of Gastrointestinal Oncology 10 (5), 910, 2019 | 17 | 2019 |
| Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy A Petrillo, MM Laterza, G Tirino, L Pompella, J Ventriglia, A Pappalardo, ... Future oncology 14 (24), 2493-2505, 2018 | 17 | 2018 |
| Naples prognostic score predicts tumor regression grade in resectable gastric cancer treated with preoperative chemotherapy E Lieto, A Auricchio, G Tirino, L Pompella, I Panarese, G Del Sorbo, ... Cancers 13 (18), 4676, 2021 | 13 | 2021 |
| Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study F Nappo, L Fornaro, L Pompella, S Catanese, D Lavacchi, A Spallanzani, ... Journal of Cancer Research and Clinical Oncology 149 (9), 6601-6611, 2023 | 10 | 2023 |
| Efficacy of a triplet and doublet-based chemotherapy as first-line therapy in patients with HER2-negative metastatic gastric cancer: a retrospective analysis from the clinical … MM Laterza, L Pompella, A Petrillo, G Tirino, A Pappalardo, M Orditura, ... Medical Oncology 34 (11), 186, 2017 | 9 | 2017 |
| Enhanced antitumor effect of trastuzumab and duligotuzumab or ipatasertib combination in HER-2 positive gastric cancer cells MM Laterza, V Ciaramella, BA Facchini, E Franzese, C Liguori, ... Cancers 13 (10), 2339, 2021 | 8 | 2021 |
| Nivolumab in heavily pretreated metastatic gastric cancer patients: real-life data from a western population A Petrillo, G Tirino, F Zito Marino, L Pompella, R Sabetta, I Panarese, ... OncoTargets and therapy, 867-876, 2020 | 8 | 2020 |
| The art of counseling in the treatment of head and neck cancer: exploratory investigation among perceptions of health professionals in southern Italy R Addeo, L Pompella, P Vitale, SIS Fattoruso, I Di Giovanni, F Perri, ... Current Oncology 29 (9), 6277-6286, 2022 | 5 | 2022 |
| Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment A Petrillo, A Pappalardo, L Pompella, G Tirino, F Calabrese, MM Laterza, ... Medical Oncology 36 (10), 83, 2019 | 5 | 2019 |
| Durable complete radiological response to Nivolumab in two heavily pretreated western elderly patients with metastatic gastric Cancer: A Case Report G Tirino, A Petrillo, L Pompella, A Pappalardo, MM Laterza, I Panarese, ... Frontiers in Oncology 10, 130, 2020 | 4 | 2020 |
| Safety and efficacy of gemcitabine/nabpaclitaxel in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis J Ventriglia, MM Laterza, B Savastano, A Petrillo, G Tirino, L Pompella, ... Annals of Oncology 28, v259, 2017 | 4 | 2017 |
| First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: a good choice beyond age. J Gastrointest Oncol. 2019 Oct; 10 (5): 910–917 A Petrillo, A Pappalardo, F Calabrese, G Tirino, L Pompella, J Ventriglia | 4 | |
| Gastric Cancer: Advanced/Metastatic Disease F De Vita, G Tirino, L Pompella, A Petrillo Practical Medical Oncology Textbook, 587-604, 2021 | 3 | 2021 |
